AACR 2011: New Phase I targeted cancer drugs
AACR 2011: New Phase I targeted cancer drugs
Ovarian cancer patients with BRCA mutations show improved survival
Heavy beer drinking and a gene variant increases gastric cancer risk
Combination therapy targeting MEK and PI3K pathways shows anti-tumour activity
New inhibitor prevents lesions and reduces tumour size in basal cell cancer
Biomarker target for lung cancer chemoprevention
Effects of stress on cancer progression
Cancer causing gene fusion in prostate cancer
New line of basic cancer biology
Scientists identify KRAS rearrangements in metastatic prostate cancer
Serum test could identify lung cancer in people who never smoked
Risk of oesophageal and stomach malignancies in people with AIDS and malignancies